CREDIT SUISSE AG/ - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
24
-99.9%
0.00%
Q1 2022$158,000
-39.0%
28,617
+6.5%
0.00%
Q4 2021$259,000
-43.8%
26,874
+4.2%
0.00%
Q3 2021$461,000
-22.1%
25,783
+6.4%
0.00%
Q2 2021$592,000
+10.4%
24,230
+19.8%
0.00%
Q1 2021$536,000
+123.3%
20,231
-36.1%
0.00%
Q4 2020$240,000
+185.7%
31,671
+87.1%
0.00%
Q3 2020$84,000
-30.6%
16,925
-15.9%
0.00%
Q2 2020$121,000
+70.4%
20,122
+25.8%
0.00%
Q1 2020$71,000
-54.5%
15,992
-2.8%
0.00%
Q4 2019$156,000
-8.8%
16,461
-24.6%
0.00%
Q3 2019$171,000
-36.4%
21,818
+27.4%
0.00%
Q2 2019$269,00017,1280.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders